James River goodwill impairment and E&S reserve development are both addressed in the company’s release for the third quarter. Third quarter results included a non-cash goodwill impairment of $181.8 million that resulted in a net loss available to common shareholders of $189.4 million, or $4.08 per diluted share.
Goodwill Origin and the Items the Impairment Charge Does Not Affect
In its press release, the company addressed the origin of the goodwill. It said the goodwill was added to the balance sheet when the Company was acquired by an investor group in 2007, rather than as a result of any acquisition made by the Company.
On the effect of the impairment, the company said the impairment charge does not affect the Company’s adjusted net operating results, statutory capital or compliance with debt covenants.
Detailed Valuation Review and Net Adverse Development in E&S Reserves
The company said in the release that each year in the third quarter it completes its Detailed Valuation Review of the E&S segment’s reserves. Following that review this year, the company recognized net adverse development of $19.2 million on total E&S net reserves of $1.0 billion. The company said the development was driven by a specific portfolio, which is fully in runoff, within the Product Liability line.
The release also states that the quarter included $19.2 million of net adverse reserve development in the E&S segment and $1.4 million of net adverse reserve development within Specialty Admitted. The company said the E&S reserve additions were informed by the Company’s annual Detailed Valuation Review process that took place during the quarter.
On recent accident years, the company said it continues to observe lower frequency and incurred losses in its more recent accident years following the significant underwriting changes made to its portfolio since 2023, and will continue to monitor these trends to inform estimates. InsuraBeat has separate coverage of combined ratio and reserve assumption updates at another insurer. InsuraBeat has separate coverage of the terms of an adverse development cover.
General and Administrative Expense Reductions and E&S Submission Growth
According to the company’s release, general and administrative expenses declined by 9% for both the quarter and on a year-to-date basis compared to prior year periods. On a year-to-date basis, expenses for Specialty Admitted declined 40% and expenses for the Corporate Segment declined 15%.
On submissions, the company said that E&S new and renewal submission growth for active divisions continues to be strong, increasing 8% compared to the prior year quarter, reflecting a strong market opportunity, while heightened competition remains across casualty lines.
Investment Income, Rate-Related Losses and the Equity Decline
Net investment income in the third quarter was $22.2 million, above the $21.9 million reported in the prior year quarter.
The release reports net realized and unrealized losses of $2.9 million for the three months ended September 30, 2026 were driven primarily by unrealized losses within the portfolio’s preferred stock holdings, whose fair values were largely impacted by rate increases during the quarter. The company said the decline in equity included a $52.0 million increase in accumulated other comprehensive loss which came as a result of the rise in rates during the year. InsuraBeat has separate coverage of net income and core earnings at another insurer.
Dividend and A.M. Best Rating
The company’s Board of Directors declared a cash dividend of $0.01 per share of common stock. The dividend is payable on Thursday, December 31, 2026 to all shareholders of record as of Tuesday, December 15, 2026.
Each of the company’s regulated insurance subsidiaries is rated “A-” (Excellent) by A.M. Best Company.